In addition, AT patients have an increased risk of developing malignant tumors, and are prone to lymphoma, leukemia, etc., and their relatives who carry heterozygous mutations in the ATM gene are also prone to various tumors, such as breast cancer and gastric cancer (28). This evidence concerns the gene ATM and lymphoma.